Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exendin-4 derivatives as selective glucagon receptor agonists

Exendin-4 derivatives as selective glucagon receptor agonists

US Patent 9932381 · Granted Apr 3, 2018

Estimated economic value: $18,243,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymer nanoparticle compositions for in vivo expression of polypeptides2025
Method for cleavage of solid phase-bound peptides from the solid phase2023
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Capping of unprotected amino groups during peptide synthesis2021
Method of preparing peptides comprising a lipophilically modified lysine side ch2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020